Cargando…
A New Deep Learning Algorithm with Activation Mapping for Diabetic Retinopathy: Backtesting after 10 Years of Tele-Ophthalmology
We report the development of a deep learning algorithm (AI) to detect signs of diabetic retinopathy (DR) from fundus images. For this, we use a ResNet-50 neural network with a double resolution, the addition of Squeeze–Excitation blocks, pre-trained in ImageNet, and trained for 50 epochs using the A...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456446/ https://www.ncbi.nlm.nih.gov/pubmed/36078875 http://dx.doi.org/10.3390/jcm11174945 |
_version_ | 1784785817559891968 |
---|---|
author | Pareja-Ríos, Alicia Ceruso, Sabato Romero-Aroca, Pedro Bonaque-González, Sergio |
author_facet | Pareja-Ríos, Alicia Ceruso, Sabato Romero-Aroca, Pedro Bonaque-González, Sergio |
author_sort | Pareja-Ríos, Alicia |
collection | PubMed |
description | We report the development of a deep learning algorithm (AI) to detect signs of diabetic retinopathy (DR) from fundus images. For this, we use a ResNet-50 neural network with a double resolution, the addition of Squeeze–Excitation blocks, pre-trained in ImageNet, and trained for 50 epochs using the Adam optimizer. The AI-based algorithm not only classifies an image as pathological or not but also detects and highlights those signs that allow DR to be identified. For development, we have used a database of about half a million images classified in a real clinical environment by family doctors (FDs), ophthalmologists, or both. The AI was able to detect more than 95% of cases worse than mild DR and had 70% fewer misclassifications of healthy cases than FDs. In addition, the AI was able to detect DR signs in 1258 patients before they were detected by FDs, representing 7.9% of the total number of DR patients detected by the FDs. These results suggest that AI is at least comparable to the evaluation of FDs. We suggest that it may be useful to use signaling tools such as an aid to diagnosis rather than an AI as a stand-alone tool. |
format | Online Article Text |
id | pubmed-9456446 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94564462022-09-09 A New Deep Learning Algorithm with Activation Mapping for Diabetic Retinopathy: Backtesting after 10 Years of Tele-Ophthalmology Pareja-Ríos, Alicia Ceruso, Sabato Romero-Aroca, Pedro Bonaque-González, Sergio J Clin Med Article We report the development of a deep learning algorithm (AI) to detect signs of diabetic retinopathy (DR) from fundus images. For this, we use a ResNet-50 neural network with a double resolution, the addition of Squeeze–Excitation blocks, pre-trained in ImageNet, and trained for 50 epochs using the Adam optimizer. The AI-based algorithm not only classifies an image as pathological or not but also detects and highlights those signs that allow DR to be identified. For development, we have used a database of about half a million images classified in a real clinical environment by family doctors (FDs), ophthalmologists, or both. The AI was able to detect more than 95% of cases worse than mild DR and had 70% fewer misclassifications of healthy cases than FDs. In addition, the AI was able to detect DR signs in 1258 patients before they were detected by FDs, representing 7.9% of the total number of DR patients detected by the FDs. These results suggest that AI is at least comparable to the evaluation of FDs. We suggest that it may be useful to use signaling tools such as an aid to diagnosis rather than an AI as a stand-alone tool. MDPI 2022-08-23 /pmc/articles/PMC9456446/ /pubmed/36078875 http://dx.doi.org/10.3390/jcm11174945 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Pareja-Ríos, Alicia Ceruso, Sabato Romero-Aroca, Pedro Bonaque-González, Sergio A New Deep Learning Algorithm with Activation Mapping for Diabetic Retinopathy: Backtesting after 10 Years of Tele-Ophthalmology |
title | A New Deep Learning Algorithm with Activation Mapping for Diabetic Retinopathy: Backtesting after 10 Years of Tele-Ophthalmology |
title_full | A New Deep Learning Algorithm with Activation Mapping for Diabetic Retinopathy: Backtesting after 10 Years of Tele-Ophthalmology |
title_fullStr | A New Deep Learning Algorithm with Activation Mapping for Diabetic Retinopathy: Backtesting after 10 Years of Tele-Ophthalmology |
title_full_unstemmed | A New Deep Learning Algorithm with Activation Mapping for Diabetic Retinopathy: Backtesting after 10 Years of Tele-Ophthalmology |
title_short | A New Deep Learning Algorithm with Activation Mapping for Diabetic Retinopathy: Backtesting after 10 Years of Tele-Ophthalmology |
title_sort | new deep learning algorithm with activation mapping for diabetic retinopathy: backtesting after 10 years of tele-ophthalmology |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456446/ https://www.ncbi.nlm.nih.gov/pubmed/36078875 http://dx.doi.org/10.3390/jcm11174945 |
work_keys_str_mv | AT parejariosalicia anewdeeplearningalgorithmwithactivationmappingfordiabeticretinopathybacktestingafter10yearsofteleophthalmology AT cerusosabato anewdeeplearningalgorithmwithactivationmappingfordiabeticretinopathybacktestingafter10yearsofteleophthalmology AT romeroarocapedro anewdeeplearningalgorithmwithactivationmappingfordiabeticretinopathybacktestingafter10yearsofteleophthalmology AT bonaquegonzalezsergio anewdeeplearningalgorithmwithactivationmappingfordiabeticretinopathybacktestingafter10yearsofteleophthalmology AT parejariosalicia newdeeplearningalgorithmwithactivationmappingfordiabeticretinopathybacktestingafter10yearsofteleophthalmology AT cerusosabato newdeeplearningalgorithmwithactivationmappingfordiabeticretinopathybacktestingafter10yearsofteleophthalmology AT romeroarocapedro newdeeplearningalgorithmwithactivationmappingfordiabeticretinopathybacktestingafter10yearsofteleophthalmology AT bonaquegonzalezsergio newdeeplearningalgorithmwithactivationmappingfordiabeticretinopathybacktestingafter10yearsofteleophthalmology |